{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:31:30Z","timestamp":1770298290085,"version":"3.49.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myocardial fibrosis occurs in cats with hypertrophic cardiomyopathy (HCM), and is one factor that leads to diastolic dysfunction. Spironolactone (SPIR) reduces myocardial fibrosis in several models of HCM and in humans with cardiac disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>SPIR will improve diastolic function and reduce left ventricular (LV) mass in Maine Coon cats with HCM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Maine Coon cats with familial HCM were included if there was concentric hypertrophy (\u22656\u2003mm end diastolic wall thickness) and decreased early lateral mitral annular velocity (Em) or summated early and late mitral annular velocity (EAsum) measured by pulsed wave tissue Doppler imaging echocardiography. Cats were paired by Em-EAsum and randomized to receive 2\u2003mg\/kg SPIR (n = 13) or placebo (n = 13) PO q12\u2003h for 4 months. Em-EAsum, systolic velocity, LV mass, and the ratio of left atrial to aortic diameter were measured at baseline, 2 months, and 4 months. Statistical analysis included 2-way repeated measures analysis of variance and the Student's t-test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Plasma aldosterone concentration increased in cats treated with SPIR (235\u2003ng\/mL, baseline; 935\u2003ng\/mL, 2 months; 1,077\u2003ng\/mL, 4 months; P &amp;lt; .001 at 2 and 4 months). No significant treatment effect was identified for early or early-late summated diastolic mitral annular velocity or any other variable except plasma aldosterone concentration. Severe facial ulcerative dermatitis developed in 4 of 13 cats treated with SPIR, requiring discontinuation of the drug.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SPIR did not improve Em or EAsum of the lateral mitral annulus or alter LV mass over 4 months. One third of cats treated with SPIR developed severe ulcerative facial dermatitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2008.0049.x","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T15:46:10Z","timestamp":1229010370000},"page":"335-341","source":"Crossref","is-referenced-by-count":43,"title":["Effect of Spironolactone on Diastolic Function and Left Ventricular Mass in Maine Coon Cats with Familial Hypertrophic Cardiomyopathy"],"prefix":"10.1093","volume":"22","author":[{"given":"K.A.","family":"MacDonald","sequence":"first","affiliation":[{"name":"University of California Department of Medicine and Epidemiology, , Davis, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Kittleson","sequence":"additional","affiliation":[{"name":"University of California Department of Medicine and Epidemiology, , Davis, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.H.","family":"Kass","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of California Department of Population Health and Reproduction, , Davis, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,3,1]]},"reference":[{"key":"2026020304193775100_b1","first-page":"435","article-title":"Molecular genetics and pathogenesis of hypertrophic cardiomyopathy","volume":"92","author":"Marian","year":"2001","journal-title":"Minerva Med"},{"key":"2026020304193775100_b2","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/hmg\/ddi386","article-title":"A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy","volume":"14","author":"Meurs","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2026020304193775100_b3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0002-9149(93)91112-U","article-title":"Comparison of morphologic findings in spontaneously occurring hypertrophic cardiomyopathy in humans, cats and dogs","volume":"72","author":"Liu","year":"1993","journal-title":"Am J Cardiol"},{"key":"2026020304193775100_b4","first-page":"3172","article-title":"Familial hypertrophic cardiomyopathy in Maine Coon cats","volume":"99","author":"Kittleson","year":"1999","journal-title":"An animal model of human disease"},{"key":"2026020304193775100_b5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2460\/ajvr.1990.51.09.1352","article-title":"Use of relaxation half-time as an index of ventricular relaxation in clinically normal cats and cats with hypertrophic cardiomyopathy","volume":"51","author":"Golden","year":"1990","journal-title":"Am J Vet Res"},{"key":"2026020304193775100_b6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0008-6363(99)00399-5","article-title":"Diastolic heart failure","volume":"45","author":"Mandinov","year":"2000","journal-title":"Cardiovasc Res"},{"key":"2026020304193775100_b7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1253\/jcj.56.325","article-title":"Histopathological factors related to diastolic function in myocardial hypertrophy","volume":"56","author":"Ohsato","year":"1992","journal-title":"Jpn Circ J"},{"key":"2026020304193775100_b8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9149(01)01640-X","article-title":"Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy","volume":"88","author":"Varnava","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026020304193775100_b9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0735-1097(99)00492-1","article-title":"Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death","volume":"35","author":"Shirani","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026020304193775100_b10","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"2026020304193775100_b11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","article-title":"Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy","volume":"109","author":"Tsybouleva","year":"2004","journal-title":"Circulation"},{"key":"2026020304193775100_b12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/jcpa.2001.0486","article-title":"Stimulation of the renin-angiotensin system in cats with hypertrophic cardiomyopathy","volume":"125","author":"Taugner","year":"2001","journal-title":"J Comp Pathol"},{"key":"2026020304193775100_b13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1939-1676.2006.tb00707.x","article-title":"The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy with no heart failure","volume":"20","author":"MacDonald","year":"2006","journal-title":"J Vet Intern Med"},{"key":"2026020304193775100_b14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ Res"},{"key":"2026020304193775100_b15","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(93)90239-9","article-title":"Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension","volume":"71","author":"Brilla","year":"1993","journal-title":"Am J Cardiol"},{"key":"2026020304193775100_b16","first-page":"809","article-title":"Collagen metabolism in cultured adult rat cardiac fibroblasts","volume":"26","author":"Brilla","year":"1994","journal-title":"Response to angiotensin II and aldosterone"},{"key":"2026020304193775100_b17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1740-8261.2005.00038.x","article-title":"Cardiac magnetic resonance imaging more accurately quantifies left ventricular mass than echocardiography in cats","volume":"46","author":"MacDonald","year":"2004","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020304193775100_b18","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2460\/ajvr.1999.60.12.1478","article-title":"Quantification of left ventricular diastolic wall motion by Doppler tissue imaging in healthy cats and cats with cardiomyopathy","volume":"60","author":"Gavaghan","year":"1999","journal-title":"Am J Vet Res"},{"key":"2026020304193775100_b19","first-page":"1596","article-title":"Beneficial neurohormonal profile of spironolactone in severe congestive heart failure","volume":"40","author":"Rousseau","year":"2002","journal-title":"Results from the RALES neurohormonal substudy"},{"key":"2026020304193775100_b20","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026020304193775100_b21","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/01.CIR.0000039104.56479.42","article-title":"Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"key":"2026020304193775100_b22","doi-asserted-by":"crossref","first-page":"H647","DOI":"10.1152\/ajpheart.2001.281.2.H647","article-title":"Effect of a selective aldosterone receptor antagonist in myocardial infarction","volume":"281","author":"Delyani","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026020304193775100_b23","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2003.05.003","article-title":"Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction","volume":"42","author":"Fraccarollo","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026020304193775100_b24","first-page":"2940","article-title":"Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy","volume":"112","author":"Izawa","year":"2005","journal-title":"A pilot study"},{"key":"2026020304193775100_b25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.amjmed.2003.12.033","article-title":"Effects of ACE gene insertion\/deletion polymorphism on response to spironolactone in patients with chronic heart failure","volume":"116","author":"Cicoira","year":"2004","journal-title":"Am J Med"},{"key":"2026020304193775100_b26","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Rigat","year":"1990","journal-title":"J Clin Invest"},{"key":"2026020304193775100_b27","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/01.CIR.92.6.1387","article-title":"Angiotensin-converting enzyme in the human heart. Effect of the deletion\/insertion polymorphism","volume":"92","author":"Danser","year":"1995","journal-title":"Circulation"},{"key":"2026020304193775100_b28","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/eurheartj\/ehi438","article-title":"Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy","volume":"26","author":"Perkins","year":"2005","journal-title":"Eur Heart J"},{"key":"2026020304193775100_b29","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0735-1097(01)01237-2","article-title":"Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype","volume":"37","author":"Cicoira","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026020304193775100_b30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.fjc.0000248236.43760.86","article-title":"Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy","volume":"48","author":"Monteiro","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026020304193775100_b31","first-page":"365","article-title":"Cutaneous drug reaction case reports","volume":"4","year":"2003","journal-title":"From the world literature"},{"key":"2026020304193775100_b32","first-page":"402","article-title":"Spironolactone-associated cutaneous effects","volume":"189","author":"Gupta","year":"1994","journal-title":"A case report and a review of the literature"},{"key":"2026020304193775100_b33","first-page":"198","article-title":"Cutaneous reaction to spironolactone resembling lupus erythematosus","volume":"24","author":"Uddin","year":"1979","journal-title":"Cutis"},{"key":"2026020304193775100_b34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.165.8.869","article-title":"Population-based drug-induced agranulocytosis","volume":"165","author":"Ibanez","year":"2005","journal-title":"Arch Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2008.0049.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/22\/2\/335\/66673807\/j.1939-1676.2008.0049.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/22\/2\/335\/66673807\/j.1939-1676.2008.0049.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:19:48Z","timestamp":1770110388000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/22\/2\/335\/8449942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2008.0049.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,3]]},"published":{"date-parts":[[2008,3,1]]}}}